Close Menu

NEW YORK – Genetics and diagnostic health testing company Prenetics said on Thursday that it has raised $15 million in a funding round led by Apis Insurtech Fund I, a venture fund managed by Apis Partners.

Existing investor Alibaba Hong Kong Entrepreneurs Fund and other investors also participated in the round. Prenetics said it has now raised more than $60 million since its inception in 2014. It will use the new funding for R&D, with a specific focus on further advancing COVID-19 testing technologies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.